hydroxyurea has been researched along with Infections, Coronavirus in 4 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 4 (100.00) | 2.80 |
| Authors | Studies |
|---|---|
| DeBaun, MR | 1 |
| Nickel, RS | 1 |
| Margulies, S | 1 |
| Frazer, B | 1 |
| Luban, NLC | 1 |
| Webb, J | 1 |
| Novelli, EM | 1 |
| Citron, F | 1 |
| Perelli, L | 1 |
| Deem, AK | 1 |
| Genovese, G | 1 |
| Viale, A | 1 |
1 trial available for hydroxyurea and Infections, Coronavirus
| Article | Year |
|---|---|
Combination dose-escalated hydroxyurea and transfusion: an approach to conserve blood during the COVID-19 pandemic.
Topics: Adolescent; Adult; Anemia, Sickle Cell; Blood Donors; Blood Safety; Blood Transfusion; Chelation The | 2020 |
3 other studies available for hydroxyurea and Infections, Coronavirus
| Article | Year |
|---|---|
Initiating adjunct low-dose hydroxyurea therapy for stroke prevention in children with SCA during the COVID-19 pandemic.
Topics: Anemia, Sickle Cell; Antisickling Agents; Blood Donors; Blood Safety; Blood Transfusion; Child; Chil | 2020 |
COVID-19 and SCA: an old friend comes to the rescue.
Topics: Betacoronavirus; Child; Coronavirus Infections; COVID-19; Friends; Humans; Hydroxyurea; Pandemics; P | 2020 |
Leukotrienes, a potential target for Covid-19.
Topics: Acetates; Adrenal Cortex Hormones; Anti-Inflammatory Agents, Non-Steroidal; Arachidonic Acid; Betaco | 2020 |